BMS 536924 is a benzimidazole derivative that acts as an inhibitor of insulin-like growth factor 1 receptor (IGF-1R) kinase. This compound is used in pharmaceutical research as a tool for studying IGF-1R signaling pathways.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing BMS 536924?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
Ticarcillin disodium salt
pharmaceutical raw material
Enoxolone
pharmaceutical raw material
17β-ethinylestradiol
pharmaceutical raw material
Betulinic acid
pharmaceutical raw material
4-[[(2S)-2-(3-chlorophenyl)-2-hydroxyethyl]amino]-3-(4-methyl-6-morpholin-4-yl-1H-benzimidazol-2-yl)-1H-pyridin-2-one
ZWVZORIKUNOTCS-OAQYLSRUSA-N
CC1=CC(=CC2=C1N=C(N2)C3=C(C=CNC3=O)NC[C@H](C4=CC(=CC=C4)Cl)O)N5CCOCC5
Sourcing BMS 536924?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.